CRSP - Crispr Therapeutics AG - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRSP is currently covered by 13 analysts with an average price target of $72.56. This is a potential upside of $20.21 (38.61%) from yesterday's end of day stock price of $52.35.

Crispr Therapeutics AG's activity chart (see below) currently has 420 price targets and 330 ratings on display. The stock rating distribution of CRSP is 88.46% BUY and 11.54% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.46% with an average time for these price targets to be met of 105.32 days.

Highest price target for CRSP is $110, Lowest price target is $44, average price target is $72.56.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 31-Aug-2026. First documented stock forecast 14-Nov-2016.

Best performing analysts who are covering CRSP - Crispr Therapeutics AG:

James Lee Joon Lee Edward Tenthoff Gil Blum Salim Syed Kostas Biliouris

Currently out of the existing stock ratings of CRSP, 23 are a BUY (88.46%), 3 are a HOLD (11.54%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-May-2022

$82

$26.57 (47.93%)

$82

1 months 7 days ago
(31-Aug-2026)

9/30 (30%)

$25.02 (43.91%)

202

Buy Since 04-Mar-2021

$80

$24.57 (44.33%)

$80

1 months 7 days ago
(31-Aug-2026)

13/27 (48.15%)

$23.02 (40.40%)

167

Buy Since 18-Apr-2024

$88

$32.57 (58.76%)

$82

2 months 4 days ago
(04-Aug-2026)

12/23 (52.17%)

$34.93 (65.82%)

134

Buy Since 03-Feb-2025

$80

$24.57 (44.33%)

$80

3 months ago
(08-Jul-2026)

5/10 (50%)

$20.8 (35.14%)

82

Hold Since 11-Jun-2026

$60

$5.08 (9.25%)

$32

3 months 27 days ago
(11-Jun-2026)

8/9 (88.89%)

$9.77 (19.45%)

254

Show more analysts

Please expand the browser size to see the chart

What is CRSP (Crispr Therapeutics AG) average time for price targets to be met?

On average it took 105 days for the stock forecasts to be reached, with an average price target met ratio of 65.46%.

Which analyst most recently updated their price target on CRSP (Crispr Therapeutics AG)?

Gil Blum

Which analyst has the most public recommendations on CRSP (Crispr Therapeutics AG)?

Gil Blum works at NEEDHAM and has 24 price targets and 23 ratings on CRSP

Which analyst is the currently most bullish on CRSP (Crispr Therapeutics AG)?

Leah Rush Cann with the highest potential upside of $143.57

Which analyst is the currently most reserved on CRSP (Crispr Therapeutics AG)?

Terence Flynn with the lowest potential downside of -$23.43
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?